1-3 of 3
Niccolò Marchionni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials

Matteo Monami, MD, PHD, Caterina Lamanna, MD, Niccolò Marchionni, MD, Edoardo Mannucci, MD
Journal: Diabetes Care
Diabetes Care 2008;31(7):1455–1460
https://doi.org/10.2337/dc07-2308
Published: 01 July 2008
View article titled, Rosiglitazone and Risk of Cancer: <subtitle>A meta-analysis of randomized clinical trials</subtitle>
Open the PDF for Rosiglitazone and Risk of Cancer: <subtitle>A meta-analysis of randomized clinical trials</subtitle> in another window
Includes: Supplementary data
Journal Articles

Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients: A case-control study

Matteo Monami, MD, PHD, Barbara Cresci, MD, Angela Colombini, MD, Laura Pala, MD, Daniela Balzi, MD, Francesca Gori, MD, Veronica Chiasserini, MD, Niccolò Marchionni, MD, Carlo Maria Rotella, MD, Edoardo Mannucci, MD
Journal: Diabetes Care
Diabetes Care 2008;31(2):199–203
https://doi.org/10.2337/dc07-1736
Published: 01 February 2008
View article titled, Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients: <subtitle>A case-control study</subtitle>
Open the PDF for Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients: <subtitle>A case-control study</subtitle> in another window
Journal Articles

Is the Third Component of Metabolic Syndrome Really Predictive of Outcomes in Type 2 Diabetic Patients?

Matteo Monami, MD, Lorella Lambertucci, MD, Andrea Ungar, MD, Maria Pieri, MD, Giulio Masotti, MD, Niccolò Marchionni, MD, Edoardo Mannucci, MD
Journal: Diabetes Care
Diabetes Care 2006;29(11):2515–2517
https://doi.org/10.2337/dc06-0330
Published: 01 November 2006
View article titled, Is the Third Component of Metabolic Syndrome Really Predictive of Outcomes in Type 2 Diabetic Patients?
Open the PDF for Is the Third Component of Metabolic Syndrome Really Predictive of Outcomes in Type 2 Diabetic Patients? in another window